News About: Pharm. Industry
Korea United to export aceclofenac to Middle East and North Africa
The Korea United Pharmaceutical Ind. said on October 6 it has signed a contract with ITROM Co. to export its Clanza (aceclofenac) CR tablets worth $2.4 million as the first shipment to countries in Middle East and Nor...
New drug-pricing reform baffles local drugmakers
Many local drug manufacturers are opposing the government’s plan to compensate the price difference when medical institutions and pharmacies are found to have bought drugs at lower prices than their government-set max...
Yuhan, Boehringer Ingelheim Korea to co-market Twynsta in Korea
Yuhan Corp. and Boehringer Ingelheim Korea announced on October 5 that the two companies have signed an agreement to co-market Twynsta (telmisartan/amlodipine) in Korea.
The domestic hypertension market is estimat...
Pharmaceutical firms in a mess
The government is implementing a plan to bring down spending on medicines, which made up over 29 percent of the country’s total medical expense in 2009. It by far exceeds the OECD average of 14.5 percent.
The Minis...
Cash incentive plan takes effect from October 1
The Ministry of Health and Welfare announced on September 30 that a new drug-pricing plan takes effect from October 1, aimed at creating a more transparent drug market and encouraging drug companies to spend more on r...
MSD Korea to reduce price of Januvia pill by 9.4%
MSD Korea said it lowered the price of Januvia 100 mg (sitagliptin phosphate), an oral diabetes medication in a new class of drugs known as DPP-4 inhibitors, from 1,020 won to 924 won on October 1.
“Januvia is an i...
Annual sales of homegrown drugs specified
Influenced by robust demand, the cumulative sales of Dong-A’s Stillen and SK Chemicals’ Joins have posted 404.5 billion won since their launching since 2002, according to the Ministry of Health and Welfare.
So far,...
Hyundai to release allergen screen topical gel
Hyundai Pharm said it has recently signed an exclusive license agreement with Nitto Pharmaceutical Industries, Ltd., to distribute NasalGuard, a topical gel used to prevent the inhalation of airborne allergens, in Kor...
Opportunities and barriers in biosimilar market
Biopharmaceutical drugs (or biologics) have outperformed the pharmaceutical market as a whole largely due to two factors: they address areas of clinical need that are unmanageable with conventional therapeutics and th...
Government OKs sale of Novartis-produced MF59-adjuvanted flu vaccine
Korea’s health authorities gave the green light to Novartis Korea to sell MF59-adjuvanted influenza vaccine for elderly people aged 65 or more.
An adjuvant is an agent that enhances the immune system's response to ...
